BioHealth Innovation, Inc.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary dedicated to translating market-relevant research into commercial success by fostering innovation, collaboration, and regional growth in the biohealth sector. It connects startups, research institutions, industry leaders, and government agencies within the BioHealth Capital Region, which includes Maryland, Virginia, and Washington, D.C. Its mission is to accelerate the development and commercialization of biohealth technologies, support startups, and promote regional economic growth through programs, partnerships, and strategic initiatives. BHI actively engages with regional leaders and experts, including board members and influential figures in the industry, to strengthen its ecosystem and regional leadership.
Industries
Nr. of Employees
small (1-50)
BioHealth Innovation, Inc.
Rockville, Maryland, United States, North America
Products
Technology Transfer and Commercialization
BioHealth Innovation facilitates the transfer and commercialization of biohealth research from federal labs, universities, and companies, connecting them with funding and management resources.
Entrepreneurial Ecosystem Development
BHI builds an entrepreneurial ecosystem by working with technology transfer offices and providing risk capital to biohealth startups.
Consulting Assistance
BHI offers consulting services to improve SBIR and other non-dilutive funding applications for biohealth projects, including grant writing support.
Soft Landing Services
BHI provides international companies with resources to establish US-based subsidiaries, offering a soft landing to grow their US business.
Startup Package
BHI collaborates with professional service providers to offer preferred rates and support for biohealth startups in Maryland.
Technology Transfer and Commercialization
BioHealth Innovation facilitates the transfer and commercialization of biohealth research from federal labs, universities, and companies, connecting them with funding and management resources.
Entrepreneurial Ecosystem Development
BHI builds an entrepreneurial ecosystem by working with technology transfer offices and providing risk capital to biohealth startups.
Consulting Assistance
BHI offers consulting services to improve SBIR and other non-dilutive funding applications for biohealth projects, including grant writing support.
Soft Landing Services
BHI provides international companies with resources to establish US-based subsidiaries, offering a soft landing to grow their US business.
Startup Package
BHI collaborates with professional service providers to offer preferred rates and support for biohealth startups in Maryland.
Services
Entrepreneur-in-Residence (EIR) Program
Placement and management of experienced entrepreneurs to provide mentorship, commercialization guidance, and business development support to academic researchers and early-stage companies.
Non-dilutive Funding Assistance
Guidance to identify, prepare, and submit grant and contract opportunities to support preclinical, translational, and early clinical development.
SBIR/STTR and Federal Funding Assistance
Targeted support for SBIR/STTR and other federal grant applications, including application review, workshops, and contact facilitation.
International Soft Landing Assistance
Support for international organizations to establish a regional presence through incubator placements, advisor networks, and market-entry resources.
Events and Regional Convening
Organization of regional forums, an annual regional week and investment conference, and related events to connect stakeholders across industry, academia, government, and investors.
Communications and Outreach (Newsletters & Podcast)
Curated newsletters, news archives, and a podcast series to disseminate regional news, program updates, and stakeholder stories.
Entrepreneur-in-Residence (EIR) Program
Placement and management of experienced entrepreneurs to provide mentorship, commercialization guidance, and business development support to academic researchers and early-stage companies.
Non-dilutive Funding Assistance
Guidance to identify, prepare, and submit grant and contract opportunities to support preclinical, translational, and early clinical development.
SBIR/STTR and Federal Funding Assistance
Targeted support for SBIR/STTR and other federal grant applications, including application review, workshops, and contact facilitation.
International Soft Landing Assistance
Support for international organizations to establish a regional presence through incubator placements, advisor networks, and market-entry resources.
Events and Regional Convening
Organization of regional forums, an annual regional week and investment conference, and related events to connect stakeholders across industry, academia, government, and investors.
Communications and Outreach (Newsletters & Podcast)
Curated newsletters, news archives, and a podcast series to disseminate regional news, program updates, and stakeholder stories.
Expertise Areas
- Technology commercialization and market assessment
- Entrepreneur-in-residence program delivery
- Non-dilutive and federal funding strategy (including SBIR/STTR)
- Regional ecosystem convening and event production
Key Technologies
- AI/ML for genomics and diagnostic interpretation
- Next-generation sequencing (exome/genome testing)
- High-resolution mass spectrometry
- Advanced spectroscopy for analytical method development